New research reveals that individuals who stop using popular GLP-1 drugs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who halt conventional lifestyle regimens.
Research printed in a major health publication shows that while overweight individuals can lose substantial amounts of their total mass while on the medication, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Users purchasing these drugs need to be informed of the potential of rapid rebound weight gain when the medication is stopped," warns expert Dr. Susan Jebb.
Such speed of recovery means a reversion to pre-treatment weight within about 18 months.
Comparing Treatments
The research, which examined dozens of trials involving thousands of participants, contrasted the effects of the injectable medications with conventional dieting.
Researchers emphasize that people who shed pounds through dieting typically see a more gradual creep back—approximately 0.1 kg a month—post-intervention.
Understanding the Quick Regain
Nutrition scientists suggest the way of the jabs is key to understanding the heightened regain.
The injections mimic a natural hormone called GLP-1, which controls appetite.
"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the body to produce less of its endogenous hormone, and could diminish responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement results in appetite is unsuppressed, making overeating far more likely."
A Chronic Disease?
Health authorities recommend the jabs for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.
Professionals argue that, given the high risk of weight regain, the treatment is often long-term.
This opinion is echoed by pharmaceutical companies, who note that the findings "emphasize the long-term character of excess weight," similar to managing diseases like high blood pressure.
User Accounts
Users who have stopped the jabs explain a intense return of hunger.
"I experienced a switch activating and you become extremely hungry," recalled a patient.
The struggle is exacerbated if individuals have not developed sustainable lifestyle or habit changes during treatment.
Growing Interest
Survey data suggest that millions of people in the UK have tried weight-loss jabs in the past year, with desire being substantial.
- Adoption is higher among women than males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the drugs through private healthcare rather than the NHS.
In conclusion, researchers stress that while GLP-1 drugs are potent tools for weight loss, they are not a standalone cure and long-term success likely depends on ongoing lifestyle management.
